Method for the Detection of Dysfunctional High Density Lipoprotein (HDL) prior to the administration of HDL raising drugs
The invention describes a new method for the detection of dysfunctional High Density Lipoprotein (HDL) prior to the administration of HDL raising drugs. HDL from patients with mild to severe CKD, is specifically associated with a component of human blood plasma which alters the endothelial effects of HDL. This novel pathomechanism leads to a HDL phenotype promoting hypertension and likely accelerating atherosclerosis even in incipient CKD that may contribute to elevated cardiovascular morbidity and mortality.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302
Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Trotting robots reveal emergence of animal gait transitions
A four-legged robot trained with machine learning by EPFL researchers has learned to avoid falls by spontaneously switching between walking, trotting, and pronking – a milestone for roboticists as well…
Innovation promises to prevent power pole-top fires
Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…
Possible alternative to antibiotics produced by bacteria
Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…
